Mycobacteriophages in diagnosis and alternative treatment of mycobacterial infections
Frontiers in Microbiology · 28.09.2023 · 14
DOI: 10.3389/fmicb.2023.1277178 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 28.09.2023. Verfasst von Xudong Ouyang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology, Weifang Medical University, Weifang, China. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Antimicrobial resistance is an increasing threat to human populations. The emergence of multidrug-resistant “superbugs” in mycobacterial infections has further complicated the processes of curing patients, thereby resulting in high morbidity and mortality. Early diagnosis and alternative treatment are important for improving the success and cure rates associated with mycobacterial infections and the use of mycobacteriophages is a potentially good option. Since each bacteriophage has its own host range, mycobacteriophages have the capacity to detect specific mycobacterial isolates. The bacteriolysis properties of mycobacteriophages make them more attractive when it comes to treating infectious diseases. In fact, they have been clinically applied in Eastern Europe for several decades. Therefore, mycobacteriophages can also treat mycobacteria infections. This review explores the potential clinical applications of mycobacteriophages, including phage-based diagnosis and phage therapy in mycobacterial infections. Furthermore, this review summarizes the current difficulties in phage therapy, providing insights into new treatment strategies against drug-resistant mycobacteria.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life Science and Technology, Weifang Medical University, Weifang, China.
- Weifang Key Laboratory of Respiratory Tract Pathogens and Drug Therapy, Weifang, China.
- SAFE Pharmaceutical Technology Co. Ltd., Beijing, China.
Zitieren
APA
Ouyang, X., Li, X., Song, J., Wang, H., Wang, S., Fang, R., Li, Z., & Song, N. (2023). Mycobacteriophages in diagnosis and alternative treatment of mycobacterial infections. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1277178
Vancouver
Ouyang X, Li X, Song J, Wang H, Wang S, Fang R, et al. Mycobacteriophages in diagnosis and alternative treatment of mycobacterial infections. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1277178
BibTeX
@article{Ouyang2023,
author = {Ouyang, Xudong and Li, Xiaotian and Song, Jinmiao and Wang, Hui and Wang, Shuxian and Fang, Ren and Li, Zhaoli and Song, Ningning},
title = {Mycobacteriophages in diagnosis and alternative treatment of mycobacterial infections},
journal = {Frontiers in Microbiology},
year = {2023},
volume = {14},
doi = {10.3389/fmicb.2023.1277178}
}
EUVIMED